compound 12d

Compound 12d refers to multiple distinct experimental small molecules identified in preclinical research. One prominent version is (3-phenylcarbamoyl-3,4-dihydro-2H-pyrrol-2-yl)phosphonate, which acts as a ligand for imidazoline 2 (I2) receptors in the brain. This compound has demonstrated potential in treating cognitive deficits, pain, and depression, notably showing sex-dependent antidepressant-like effects in male rats. Another compound designated as 12d is a benzimidazolone-bridged hybrid containing a coumarin moiety, which has been evaluated for its antiproliferative activity against various cancer cell lines, including HeLa, A549, and MCF-7. This anticancer variant is thought to target VEGFR2 and CDK4-Cyclin D3. Both versions remain in the preclinical stage of development and have not been assigned brand names or commercial developers.

Other names

(3-phenylcarbamoyl-3,4-dihydro-2H-pyrrol-2-yl)phosphonatebenzimidazolone-coumarin hybrid 12d